$ RGBP NEWS! The latest progress Updated for #NR2F6 nuclear receptor program an important #immune cell inhibitor #cancer stem cell differentiator https://buff.ly/2DKvbY8 @RegenBioPharm is a publicly traded biotechnology company (OTCQB:RGBP) http://www.frontpagestocks.com/regen-biopharma-inc-rgbp/